Page 30. 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

Page 30. https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf

 

 

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-top-line-results

 https://clinicaltrials.gov/ct2/show/NCT03732807

 https://www.bitchute.com/video/tDDDi4IqaQRp/

Related 

 https://shore-215.blogspot.com/2022/04/broadcast-delay.html

https://shore-215.blogspot.com/2022/03/the-will-smith-slap-and-pfizer.html

 https://shore-215.blogspot.com/search?q=pfizer